Patient Guide: A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 114 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06330064
Status: 🟢 Enrolling Now
Condition: Recurrent or Metastatic Solid Tumors
Phase: PHASE2

Where You Can Participate

This study is available at 114 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Los Angeles, California
  • • Whittier, California
  • • And 111 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) - Join Clinical Trial NCTNCT06330064

How to Join This Clinical Trial - NCTNCT06330064

Learn how to participate in this PHASE2 trial studying an investigational therapy for Recurrent or Metastatic Solid Tumors. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Recurrent or Metastatic Solid Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Recurrent or Metastatic Solid Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06330064 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 114 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90017 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90067 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Whittier, California 90602 - United States

Status: RECRUITING

Clinical Research Site

Skokie, Illinois 60077 - United States

Status: RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55455 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10016 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10029 - United States

Status: RECRUITING

Clinical Research Site

Westbury, New York 11590 - United States

Status: RECRUITING

Clinical Research Site

Chattanooga, Tennessee 37403 - United States

Status: RECRUITING

Clinical Research Site

Germantown, Tennessee 38138 - United States

Status: RECRUITING

And 104 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Recurrent or Metastatic Solid Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships